Inicio › Mielofibrosis › Massachusetts › Boston
Ensayos clínicos de Mielofibrosis en Boston, MA
13 estudios para Mielofibrosis buscan participantes en centros de Boston y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
ReclutandoFase 1
- Massachusetts General Hospital, Boston
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
ReclutandoFase 1
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
ReclutandoFase 3
- Tufts Medical Center, Boston
A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms
ReclutandoFase 1
- Site US03, Boston
- Site US12, Boston
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
ReclutandoFase 2Se aceptan voluntarios sanos
- DFCI/BWH Brigham and Women's Hospital, Boston
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
ReclutandoFase 1Se aceptan voluntarios sanos
- Brigham and Women's Hospital, Boston
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
ReclutandoFase 1/2
- Massachusetts General Hospital, Boston
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
ReclutandoFase 1/2
- Massachusetts General Hospital (Data Collection Only), Boston
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
ReclutandoFase 1
- Dana Farber Cancer Institute, Boston
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
ReclutandoFase 1
- Dana Farber Cancer Institute, Boston
Momelotinib During and After HCT in Myelofibrosis
ReclutandoFase 1
- Massachusetts General Hospital, Boston
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
ReclutandoFase 2
- Dana-Farber Cancer Institute, Boston
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
ReclutandoFase 3
- Dana Farber Cancer Institute, Boston
Ensayos de Mielofibrosis en otras ciudades
- New York City, NY21 estudios
- Houston, TX20 estudios
- Durham, NC13 estudios
- Columbus, OH12 estudios
- Seattle, WA12 estudios
- Tampa, FL11 estudios
- Nashville, TN11 estudios
- Miami, FL11 estudios
- Salt Lake City, UT11 estudios
- Ann Arbor, MI10 estudios
- Atlanta, GA10 estudios
- Baldwin Park, CA10 estudios
Otros estudios en Boston
- Cáncer de seno110 estudios
- Cáncer (todos los tipos)90 estudios
- Cáncer de pulmón de células no pequeñas87 estudios
- Cáncer de pulmón63 estudios
- Cáncer del colon y del recto62 estudios
- Cáncer de ovario62 estudios
- Cáncer metastásico61 estudios
- Cáncer de próstata56 estudios
- Cáncer de endometrio51 estudios
- Depresión50 estudios
- Fallo cardíaco46 estudios
- Mieloma múltiple45 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.